Recordati - Ind.Chim.Farm. SpA Aktie

Recordati Industria Chimica e Farmaceutica S.p.A., along with its various divisions, functions as a global pharmaceutical firm. Its core operations involve the research, development, production, commercialization, and worldwide distribution of medicinal products. The company's diverse portfolio covers an extensive spectrum of therapeutic areas, including cardiovascular health, dermatology, urology, anti-infectives, central nervous system disorders, gastrointestinal conditions, gynecology, musculoskeletal ailments, and pain management. Furthermore, Recordati supplies over-the-counter remedies, generic drugs, oncology treatments, and solutions for allergies, endocrine issues, and respiratory illnesses, encompassing even ear, nose, and throat preparations. Complementing its pharmaceutical offerings are nutritional products, cosmetics, dietary supplements, and medical devices. Additionally, the firm is a prominent provider of treatments for rare diseases and produces specialized pharmaceutical chemicals, such as active pharmaceutical ingredients (APIs), intermediates, and complex chemical syntheses. Established in Milan, Italy, in 1926, Recordati Industria Chimica e Farmaceutica S.p.A. currently operates as a subsidiary of Rossini S.à R.L.